157 related articles for article (PubMed ID: 11805237)
1. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells.
Kim KY; Shin HK; Choi JM; Hong KW
J Pharmacol Exp Ther; 2002 Feb; 300(2):709-15. PubMed ID: 11805237
[TBL] [Abstract][Full Text] [Related]
2. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation.
Kim MJ; Lee JH; Park SY; Hong KW; Kim CD; Kim KY; Lee WS
Pharmacol Res; 2006 Oct; 54(4):261-7. PubMed ID: 16822680
[TBL] [Abstract][Full Text] [Related]
3. Prevention of lipopolysaccharide-induced apoptosis by (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a benzopyran analog, in endothelial cells.
Kim KY; Kim BG; Kim SO; Yoo SE; Kwak YG; Chae SW; Hong KW
J Pharmacol Exp Ther; 2002 Feb; 300(2):535-42. PubMed ID: 11805214
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.
Lim JH; Woo JS; Shin YW
Korean J Intern Med; 2009 Jun; 24(2):113-22. PubMed ID: 19543489
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
[TBL] [Abstract][Full Text] [Related]
6. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax.
Haendeler J; Zeiher AM; Dimmeler S
Eur J Pharmacol; 1996 Dec; 317(2-3):407-11. PubMed ID: 8997628
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.
Choi JM; Shin HK; Kim KY; Lee JH; Hong KW
J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782
[TBL] [Abstract][Full Text] [Related]
8. Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax.
Hu L; Sun Y; Hu J
Eur J Pharmacol; 2010 Feb; 628(1-3):155-63. PubMed ID: 19962976
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells.
Messmer UK; Briner VA; Pfeilschifter J
Kidney Int; 1999 Jun; 55(6):2322-37. PubMed ID: 10354280
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
[TBL] [Abstract][Full Text] [Related]
11. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.
Shin HK; Kim YK; Kim KY; Lee JH; Hong KW
Circulation; 2004 Mar; 109(8):1022-8. PubMed ID: 14967724
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
Nakamura K; Ikomi F; Ohhashi T
J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory action of cilostazol, a phosphodiesterase III inhibitor, on catecholamine secretion from cultured bovine adrenal chromaffin cells.
Azuma M; Houchi H; Mizuta M; Kinoshita M; Teraoka K; Minakuchi K
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S29-32. PubMed ID: 12688393
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction.
Park SY; Lee SW; Shin HK; Chung WT; Lee WS; Rhim BY; Hong KW; Kim CD
Arthritis Rheum; 2010 Mar; 62(3):732-41. PubMed ID: 20131233
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
Ota H; Eto M; Kano MR; Ogawa S; Iijima K; Akishita M; Ouchi Y
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1634-9. PubMed ID: 18556572
[TBL] [Abstract][Full Text] [Related]
17. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Hashimoto A; Miyakoda G; Hirose Y; Mori T
Atherosclerosis; 2006 Dec; 189(2):350-7. PubMed ID: 16545819
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells.
Wu SN; Liu SI; Huang MH
Endocrinology; 2004 Mar; 145(3):1175-84. PubMed ID: 14645120
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation.
Hong KW; Kim KY; Shin HK; Lee JH; Choi JM; Kwak YG; Kim CD; Lee WS; Rhim BY
J Pharmacol Exp Ther; 2003 Sep; 306(3):1182-90. PubMed ID: 12807996
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
